In addition, siRNA knockdown of RIPK1 expression also inhibited the phosphorylation levels of these proteins, revealing that RIPK1 had regulatory function on NF-κB activity in NSCLC cells. The gene discussed is NFKB1; the disease is non-small cell lung carcinoma.